NONMEM Users Network Archive

Hosted by Cognigen

Modelling & Simulation Position at AstraZeneca

From: Jansson Löfmark, Rasmus <Rasmus.Jansson.Lofmark >
Date: Fri, 20 May 2016 20:28:58 +0000

Modelling & Simulation Position at AstraZeneca

The role is focused on modelling and simulation (M&S) techniques to help dr=
ug discovery projects to understand and integrate in-vitro and in-vivo abso=
rption, distribution and metabolism (ADME) properties and pharmacokinetic (=
PK) and pharmacodynamic (PD) properties, including biomarkers for mechanism=
 of action. The role will be based in Gothenburg, Sweden

Major responsibilities:
Define and deliver the translational quantitative/PKPD strategy fo=
r efficacy and target safety, in projects from target identification to lif=
e-cycle management.
Identify the appropriate M&S approach (e.g. traditional PKPD model=
ling, non-linear mixed effects modelling, quantitative systems pharmacology=
) to deliver the aforementioned.
Design preclinical PKPD studies and report results and interpretat=
ions to project teams and internal governance bodies.
In collaboration with key functions (e.g. bioscientists, translat=
ional scientists, safety scientists, clinical pharmacology and clinical pha=
rmacometricians) integrate the appropriate data to predict human pharmacoki=
netics, efficacious drug exposure, human longitudinal response (e.g. biomar=
ker and disease effects), and human dosing regimen.
Contribute to estimation of safety margins and make recommendation=
s and predictions on human efficacious dose and exposure.

Deliver drug-drug interaction (DDI) predictions and risk assessmen=
ts to project teams. Contribute proactively to an innovative working enviro=
nment where improvements and new ideas are adopted and freely shared. Conti=
nuously display scientific progress externally and internally.

Key Deliverables: Deliver the PK, DDI and PKPD elements to project teams wi=
thin the agreed timelines and to the right quality

PhD or equivalent level of experience in mathematical modelling an=
d simulation of PK/PD, biological systems, quantitative systems pharmacolo=
gy and ideally in a preclinical/translational setting
Specialist in modelling and simulation tools such as Matlab, R, NO=
NMEM, WinNonlin/Phoenix NLME, SimCyp
Experience of defining quantitative modelling strategies across se=
veral therapeutic modalities (e.g. small molecules, oligonucleotides, prote=
ins, antibodies)
Track record of ability to meet timelines to pre-specified quality=
 and cost
Understanding of integrative aspects of DMPK and pharmacology/safe=
ty aspects of drug discovery and development
Experience in pharmaceutical R&D and experience in operating cross=

For further information see below:

or contact:


Confidentiality Notice: This message is private and may contain confidentia=
l and proprietary information. If you have received this message in error, =
please notify us and remove it from your system and note that you must not =
copy, distribute or take any action in reliance on it. Any unauthorized use=
 or disclosure of the contents of this message is not permitted and may be =

Received on Fri May 20 2016 - 16:28:58 EDT

The NONMEM Users Network is maintained by ICON plc. Requests to subscribe to the network should be sent to:

Once subscribed, you may contribute to the discussion by emailing: